Highlights for the
- Revenue of
$2.44 billion . - U.S. GAAP gross margin of 44.0%, U.S. GAAP operating income as a percentage of revenue of 23.2%, and U.S. GAAP diluted EPS of
$3.47 . - Non-GAAP gross margin of 45.1%, non-GAAP operating income as a percentage of revenue of 25.1%, and non-GAAP diluted EPS of
$3.70 .
Key Financial Data for the Quarters Ended
March 31, 2019 and December 23, 2018
(in thousands, except per-share data, percentages, and basis points)
U.S. GAAP | |||||||||||
March 2019 | December 2018 | Change Q/Q | |||||||||
Revenue | $ | 2,439,048 | $ | 2,522,673 | - 3 | % | |||||
Gross margin as percentage of revenue | 44.0 | % | 45.4 | % | - 140 | bps | |||||
Operating income as percentage of revenue | 23.2 | % | 27.4 | % | - 420 | bps | |||||
Diluted EPS | $ | 3.47 | $ | 3.51 | - 1 | % | |||||
Non-GAAP | |||||||||||
March 2019 | December 2018 | Change Q/Q | |||||||||
Revenue | $ | 2,439,048 | $ | 2,522,673 | - 3 | % | |||||
Gross margin as percentage of revenue | 45.1 | % | 46.3 | % | - 120 | bps | |||||
Operating income as percentage of revenue | 25.1 | % | 28.8 | % | - 370 | bps | |||||
Diluted EPS | $ | 3.70 | $ | 3.87 | - 4 | % |
U.S. GAAP Financial Results
For the
Non-GAAP Financial Results
For the
“Lam’s March quarter results demonstrate strong execution in a challenging near-term industry environment,” said
Balance Sheet and Cash Flow Results
Cash and cash equivalents, short-term investments, and restricted cash and investments balances increased to
Deferred revenue and deferred profit at the end of the
Geographic Distribution
The geographic distribution of revenue during the
Region | Revenue | |
Korea | 25 | % |
Taiwan | 23 | % |
Japan | 17 | % |
China | 17 | % |
United States | 9 | % |
Southeast Asia | 5 | % |
Europe | 4 | % |
Outlook
For the
U.S. GAAP | Reconciling Items | Non-GAAP | ||||||||||||||||||
Revenue | $2.35 Billion | +/- | $150 Million | — | $2.35 Billion | +/- | $150 Million | |||||||||||||
Gross margin as a percentage of revenue | 45.4 | % | +/- | 1 | % | $ | 3 | Million | 45.5 | % | +/- | 1 | % | |||||||
Operating income as a percentage of revenue | 25.3 | % | +/- | 1 | % | $ | 16 | Million | 26.0 | % | +/- | 1 | % | |||||||
Net income per diluted share | $ | 3.31 | +/- | $ | 0.20 | $ | 14 | Million | $ | 3.40 | +/- | $ | 0.20 | |||||||
Diluted share count | 155 Million | — | 155 Million |
The information provided above is only an estimate of what the Company believes is realizable as of the date of this release, and does not incorporate the potential impact of any business combinations, asset acquisitions, divestitures, restructuring, balance sheet valuation adjustments, financing arrangements, other investments, or other significant transactions that may be completed after the date of this release. U.S. GAAP to non-GAAP reconciling items provided include only those items that are known and can be estimated as of the date of this release. Actual results will vary from this model and the variations may be material. Reconciling items included above are as follows:
- Gross margin as a percentage of revenue - amortization related to intangible assets acquired through business combinations,
$3 million . - Operating income as a percentage of revenue - amortization related to intangible assets acquired through business combinations,
$16 million . - Earnings per share - amortization related to intangible assets acquired though business combinations,
$16 million ; amortization of note discounts,$1 million ; and associated tax benefit for non-GAAP items ($3 million ); totaling$14 million .
Use of Non-GAAP Financial Results
In addition to U.S. GAAP results, this press release also contains non-GAAP financial results. The Company’s non-GAAP results for both the
Management uses non-GAAP gross margin, operating expense, operating income, net income, and net income per diluted share to evaluate the Company’s operating and financial results. The Company believes the presentation of non-GAAP results is useful to investors for analyzing business trends and comparing performance to prior periods, along with enhancing investors’ ability to view the Company’s results from management’s perspective. Tables presenting reconciliations of non-GAAP results to U.S. GAAP results are included at the end of this press release and on the Company’s website at http://investor.lamresearch.com.
Caution Regarding Forward-Looking Statements
Statements made in this press release that are not of historical fact are forward-looking statements and are subject to the safe harbor provisions created by the Private Securities Litigation Reform Act of 1995. Such forward-looking statements relate to, but are not limited to: our focus on customer needs; our investments to extend differentiation in our products and services; the estimated future revenue from shipments to customers in
About
Consolidated Financial Tables Follow.
LAM RESEARCH CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except per share data and percentages)
(unaudited)
Three Months Ended | Nine Months Ended | ||||||||||||||||||
March 31, 2019 |
December 23, 2018 |
March 25, 2018 |
March 31, 2019 |
March 25, 2018 |
|||||||||||||||
Revenue | $ | 2,439,048 | $ | 2,522,673 | $ | 2,892,115 | $ | 7,292,412 | $ | 7,951,070 | |||||||||
Cost of goods sold | 1,364,711 | 1,377,640 | 1,561,401 | 4,014,844 | 4,265,446 | ||||||||||||||
Gross margin | 1,074,337 | 1,145,033 | 1,330,714 | 3,277,568 | 3,685,624 | ||||||||||||||
Gross margin as a percent of revenue | 44.0 | % | 45.4 | % | 46.0 | % | 44.9 | % | 46.4 | % | |||||||||
Research and development | 318,514 | 285,556 | 305,412 | 895,742 | 861,801 | ||||||||||||||
Selling, general and administrative | 190,306 | 169,098 | 197,791 | 534,179 | 565,719 | ||||||||||||||
Total operating expenses | 508,820 | 454,654 | 503,203 | 1,429,921 | 1,427,520 | ||||||||||||||
Operating income | 565,517 | 690,379 | 827,511 | 1,847,647 | 2,258,104 | ||||||||||||||
Operating income as a percent of revenue | 23.2 | % | 27.4 | % | 28.6 | % | 25.3 | % | 28.4 | % | |||||||||
Other income (expense), net | 20,532 | (30,649 | ) | (55,810 | ) | (10,494 | ) | (64,464 | ) | ||||||||||
Income before income taxes | 586,049 | 659,730 | 771,701 | 1,837,153 | 2,193,640 | ||||||||||||||
Income tax (expense) benefit | (38,659 | ) | (90,875 | ) | 7,099 | (187,548 | ) | (834,105 | ) | ||||||||||
Net income | $ | 547,390 | $ | 568,855 | $ | 778,800 | $ | 1,649,605 | $ | 1,359,535 | |||||||||
Net income per share: | |||||||||||||||||||
Basic | $ | 3.62 | $ | 3.67 | $ | 4.80 | $ | 10.72 | $ | 8.40 | |||||||||
Diluted | $ | 3.47 | $ | 3.51 | $ | 4.33 | $ | 10.20 | $ | 7.45 | |||||||||
Number of shares used in per share calculations: | |||||||||||||||||||
Basic | 151,201 | 155,022 | 162,378 | 153,891 | 161,885 | ||||||||||||||
Diluted | 157,849 | 162,170 | 179,779 | 161,683 | 182,565 | ||||||||||||||
Cash dividend declared per common share | $ | 1.10 | $ | 1.10 | $ | 0.50 | $ | 3.30 | $ | 1.45 |
LAM RESEARCH CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands)
March 31, 2019 |
December 23, 2018 |
June 24, 2018 |
||||||||||
(unaudited) | (unaudited) | (1) | ||||||||||
ASSETS | ||||||||||||
Cash and cash equivalents | $ | 4,931,611 | $ | 3,359,793 | $ | 4,512,257 | ||||||
Investments | 1,209,315 | 275,670 | 437,338 | |||||||||
Accounts receivable, net | 1,522,273 | 1,868,842 | 2,176,936 | |||||||||
Inventories | 1,622,242 | 1,703,307 | 1,876,162 | |||||||||
Prepaid expenses and other current assets | 156,800 | 148,233 | 147,218 | |||||||||
Total current assets | 9,442,241 | 7,355,845 | 9,149,911 | |||||||||
Property and equipment, net | 1,040,329 | 1,013,306 | 902,547 | |||||||||
Restricted cash and investments | 255,774 | 255,292 | 256,301 | |||||||||
Goodwill and intangible assets | 1,707,930 | 1,736,468 | 1,802,740 | |||||||||
Other assets | 448,988 | 407,547 | 367,979 | |||||||||
Total assets | $ | 12,895,262 | $ | 10,768,458 | $ | 12,479,478 | ||||||
LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||||||||
Current portion of convertible notes, capital leases and commercial paper | $ | 964,107 | $ | 187,102 | $ | 610,030 | ||||||
Other current liabilities | 1,841,521 | 1,979,735 | 2,540,278 | |||||||||
Total current liabilities | 2,805,628 | 2,166,837 | 3,150,308 | |||||||||
Long-term debt and capital leases | 3,801,514 | 1,813,190 | 1,806,562 | |||||||||
Income taxes payable | 863,155 | 859,232 | 851,936 | |||||||||
Other long-term liabilities | 83,986 | 87,827 | 90,629 | |||||||||
Total liabilities | 7,554,283 | 4,927,086 | 5,899,435 | |||||||||
Temporary equity, convertible notes | 49,783 | 57,009 | 78,192 | |||||||||
Stockholders’ equity (2) | 5,291,196 | 5,784,363 | 6,501,851 | |||||||||
Total liabilities and stockholders’ equity | $ | 12,895,262 | $ | 10,768,458 | $ | 12,479,478 |
(1 | ) | Derived from audited financial statements. |
(2 | ) | Common shares issued and outstanding were 149,886 as of March 31, 2019, 153,961 as of December 23, 2018, and 156,892 as of June 24, 2018. |
LAM RESEARCH CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands, unaudited)
Three Months Ended | Nine Months Ended | ||||||||||||||||||
March 31, 2019 |
December 23, 2018 |
March 25, 2018 |
March 31, 2019 |
March 25, 2018 |
|||||||||||||||
CASH FLOWS FROM OPERATING ACTIVITIES: | |||||||||||||||||||
Net income | $ | 547,390 | $ | 568,855 | $ | 778,800 | $ | 1,649,605 | $ | 1,359,535 | |||||||||
Adjustments to reconcile net income to net cash provided by operating activities: | |||||||||||||||||||
Depreciation and amortization | 82,274 | 81,794 | 82,236 | 243,873 | 241,276 | ||||||||||||||
Deferred income taxes | (12,401 | ) | 20,797 | 19,060 | (75,105 | ) | (209,214 | ) | |||||||||||
Equity-based compensation expense | 53,240 | 38,806 | 41,095 | 142,389 | 125,002 | ||||||||||||||
Impairment of investment | — | — | 42,456 | — | 42,456 | ||||||||||||||
Amortization of note discounts and issuance costs | 2,861 | 1,031 | 4,342 | 5,137 | 13,469 | ||||||||||||||
Other, net | (1,494 | ) | (1,343 | ) | 17,866 | (646 | ) | 23,327 | |||||||||||
Changes in operating assets and liabilities | 260,951 | (67,521 | ) | 64,524 | 330,273 | 341,538 | |||||||||||||
Net cash provided by operating activities | 932,821 | 642,419 | 1,050,379 | 2,295,526 | 1,937,389 | ||||||||||||||
CASH FLOWS FROM INVESTING ACTIVITIES: | |||||||||||||||||||
Capital expenditures and intangible assets | (75,522 | ) | (105,923 | ) | (49,057 | ) | (237,543 | ) | (193,814 | ) | |||||||||
Business acquisition, net of cash acquired | — | — | — | — | (115,697 | ) | |||||||||||||
Net (purchase) sale of available-for-sale securities | (931,380 | ) | 773,223 | 2,134,886 | (770,740 | ) | 1,811,411 | ||||||||||||
Other, net | (1,269 | ) | (369 | ) | 638 | (5,288 | ) | (14,358 | ) | ||||||||||
Net cash (used for) provided by investing activities | (1,008,171 | ) | 666,931 | 2,086,467 | (1,013,571 | ) | 1,487,542 | ||||||||||||
CASH FLOWS FROM FINANCING ACTIVITIES: | |||||||||||||||||||
Principal payments on debt | (30,225 | ) | (6,440 | ) | (228,166 | ) | (116,496 | ) | (577,415 | ) | |||||||||
Net proceeds (repayments) from issuance of commercial paper | 297,850 | (359,518 | ) | 199,024 | (61,754 | ) | 997,971 | ||||||||||||
Proceeds from borrowings on revolving credit facility | — | — | — | — | 750,000 | ||||||||||||||
Repayments of borrowings on revolving credit facility | — | — | — | — | (750,000 | ) | |||||||||||||
Proceeds from issuance of long-term debt, net of issuance costs | 2,476,720 | — | — | 2,476,720 | — | ||||||||||||||
Treasury stock purchases | (934,637 | ) | (1,519 | ) | (80,105 | ) | (2,672,051 | ) | (1,346,940 | ) | |||||||||
Dividends paid | (171,196 | ) | (167,907 | ) | (79,739 | ) | (513,475 | ) | (225,604 | ) | |||||||||
Reissuance of treasury stock related to employee stock purchase plan | — | 32,920 | — | 32,920 | 34,057 | ||||||||||||||
Proceeds from issuance of common stock | 5,010 | 109 | 2,517 | 5,119 | 6,632 | ||||||||||||||
Other, net | — | (13,198 | ) | 7 | (13,207 | ) | 11 | ||||||||||||
Net cash provided by (used for) financing activities | 1,643,522 | (515,553 | ) | (186,462 | ) | (862,224 | ) | (1,111,288 | ) | ||||||||||
Effect of exchange rate changes on cash, cash equivalents, and restricted cash | 4,128 | (2,721 | ) | 4,041 | (904 | ) | 8,200 | ||||||||||||
Net increase in cash, cash equivalents, and restricted cash | 1,572,300 | 791,076 | 2,954,425 | 418,827 | 2,321,843 | ||||||||||||||
Cash, cash equivalents, and restricted cash at beginning of period | 3,615,085 | 2,824,009 | 2,001,157 | 4,768,558 | 2,633,739 | ||||||||||||||
Cash, cash equivalents, and restricted cash at end of period | $ | 5,187,385 | $ | 3,615,085 | $ | 4,955,582 | $ | 5,187,385 | $ | 4,955,582 |
Non-GAAP Financial Summary
(in thousands, except percentages and per share data)
(unaudited)
Three Months Ended | |||||||
March 31, 2019 |
December 23, 2018 |
||||||
Revenue | $ | 2,439,048 | $ | 2,522,673 | |||
Gross margin | $ | 1,099,550 | $ | 1,167,375 | |||
Gross margin as percentage of revenue | 45.1 | % | 46.3 | % | |||
Operating expenses | $ | 488,389 | $ | 439,808 | |||
Operating income | $ | 611,161 | $ | 727,567 | |||
Operating income as a percentage of revenue | 25.1 | % | 28.8 | % | |||
Net income | $ | 584,350 | $ | 628,196 | |||
Net income per diluted share | $ | 3.70 | $ | 3.87 | |||
Shares used in per share calculation - diluted | 157,849 | 162,170 |
Reconciliation of U.S. GAAP Net Income to Non-GAAP Net Income
(in thousands, except per share data)
(unaudited)
Three Months Ended | |||||||
March 31, 2019 | December 23, 2018 | ||||||
U.S. GAAP net income | $ | 547,390 | $ | 568,855 | |||
Pre-tax non-GAAP items: | |||||||
Amortization related to intangible assets acquired through certain business combinations - cost of goods sold | 22,342 | 22,342 | |||||
Restructuring charges - cost of goods sold | 2,871 | — | |||||
Restructuring charges - research and development | 4,698 | — | |||||
Amortization related to intangible assets acquired through certain business combinations - selling, general and administrative | 12,446 | 12,490 | |||||
Restructuring charges - selling, general and administrative | 3,287 | 2,356 | |||||
Amortization of note discounts - other expense, net | 956 | 886 | |||||
Net income tax benefit on non-GAAP items | (6,718 | ) | (5,704 | ) | |||
Income tax benefit on the conclusion of certain tax matters | (2,922 | ) | (1,635 | ) | |||
Income tax expense associated with U.S. tax reform | — | 28,606 | |||||
Non-GAAP net income | $ | 584,350 | $ | 628,196 | |||
Non-GAAP net income per diluted share | $ | 3.70 | $ | 3.87 | |||
GAAP net income per diluted share | $ | 3.47 | $ | 3.51 | |||
U.S. GAAP number of shares used for per diluted share calculation | 157,849 | 162,170 |
Reconciliation of U.S. GAAP Gross Margin, Operating Expenses and Operating Income to Non-GAAP Gross Margin, Operating Expenses and Operating Income
(in thousands, except percentages)
(unaudited)
Three Months Ended | |||||||
March 31, 2019 |
December 23, 2018 |
||||||
U.S. GAAP gross margin | $ | 1,074,337 | $ | 1,145,033 | |||
Pre-tax non-GAAP items: | |||||||
Amortization related to intangible assets acquired through certain business combinations | 22,342 | 22,342 | |||||
Restructuring charges | 2,871 | — | |||||
Non-GAAP gross margin | $ | 1,099,550 | $ | 1,167,375 | |||
U.S. GAAP gross margin as a percentage of revenue | 44.0 | % | 45.4 | % | |||
Non-GAAP gross margin as a percentage of revenue | 45.1 | % | 46.3 | % | |||
U.S. GAAP operating expenses | $ | 508,820 | $ | 454,654 | |||
Pre-tax non-GAAP items: | |||||||
Amortization related to intangible assets acquired through certain business combinations | (12,446 | ) | (12,490 | ) | |||
Restructuring charges | (7,985 | ) | (2,356 | ) | |||
Non-GAAP operating expenses | $ | 488,389 | $ | 439,808 | |||
U.S. GAAP operating income | $ | 565,517 | $ | 690,379 | |||
Non-GAAP operating income | $ | 611,161 | $ | 727,567 | |||
U.S. GAAP operating income as percent of revenue | 23.2 | % | 27.4 | % | |||
Non-GAAP operating income as a percent of revenue | 25.1 | % | 28.8 | % |
Lam Research Corporation Contacts:
Source: Lam Research Corporation